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DISTIGUISHING EARLY STAGE CHRONIC TRAUMATIC 
ENCEPHALOPATHY FROM PERSISTENT POST-CONCUSSION SYNDROME 
ANDREW DEVOID 
ABSTRACT 
Background 
Sports-related head trauma has become a major public health concern with significant 
consequences including persistent post-concussion syndrome (pPCS) and chronic 
traumatic encephalopathy (CTE).  pPCS is a condition where symptoms of single 
concussion persist years beyond the initial injury.  CTE has been characterized as a 
condition with insidious onset following a latent period after substantial exposure to 
repetitive head impacts (RHI).  Timing of symptom onset usually distinguishes these 
conditions, however in certain clinical situations a definitive diagnosis is not always 
clear.  For these situations, a measurable distinguishing variable is necessary.   
Literature Review 
Concussions are the most common form of traumatic brain injury (TBI) and are 
associated with a variety of neurological symptoms that usually resolve within weeks.  
Post-concussion syndrome (PCS) refers to cases where symptoms continue months 
beyond this window, and pPCS is defined as symptoms continuing over years.  These 
conditions are temporally related single concussive events.  CTE is the hallmark 
condition related to RHI and remains difficult to fully characterize as it currently can only 
be diagnosed post-mortem.  Clinical features of CTE are similar to those of pPCS with 
notable behavioral/mood symptoms in its earliest stages, and progression to severe 
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cognitive decline over time.  Current research has shown executive dysfunction to be a 
common impairment among these conditions.  The difference in level of dysfunction 
between them, if one exists, is yet to be measured.    
Proposed Project 
A cross-sectional analysis of executive function in four groups.  A control without history 
of mTBI or football exposure (Non-Football – pPCS), a second control of asymptomatic 
subjects with football exposure (Football – pPCS), a group of pPCS patients with non-
athletic mTBI history (Non-Football + pPCS), and a group of pPCS patients with football 
exposure (Football + pPCS).  Executive functioning will be evaluated using the BRIEF-A 
assessment.  Results will be compared to determine if significant differences in executive 
functioning exist between the groups.  
Conclusions 
With previous studies showing a correlation between CTE pathological stage, worsening 
executive function, and increased RHI exposure, further investigation into using 
executive function as a distinguishing variable between early stage CTE and pPCS is 
warranted. 
Significance 
Results of this study, if significant, could be applied clinically to assess risk of early stage 
CTE in athletes with prolonged post-concussion symptoms.  If results are not significant, 
they may still be utilized for a better understanding of the effects of isolated mTBIs and 
RHI on executive functioning, and provide valuable information for ongoing longitudinal 
studies.  
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INTRODUCTION 
Background 
The potential long-term consequences of contact sports-related head trauma have become 
a significant public health concern over the last decade with a major focus on the 
spectrum of neurologic conditions associated with the acute and chronic implications of 
traumatic brain injuries (TBI) and repetitive head impacts (RHI).  A great deal of this 
concern has centered around concussions, which are considered a subset of mild TBI 
(mTBI) and are the most common form of sports-related TBI.  These injuries result from 
traumatic forces on the brain leading to a potential constellation of several neuro-
cognitive symptoms which tend resolve within a week’s time in the majority of cases.   
In up to 30% of concussion cases however, symptoms may linger beyond the 
acute phase in a condition known as post-concussion syndrome (PCS).15  In up to 15% of 
cases, symptoms may even progress years beyond the initial injury in what is termed 
persistent post-concussion syndrome (pPCS).15  The clinical features of pPCS can involve 
many neuropsychological and cognitive components which have even been noted to be 
progressive in some cases, especially with regard to behavior and mood symptoms.12  
Though a variety of factors may contribute to the development and course of pPCS, the 
defining characteristic of this condition is its temporal link to a specific concussive event, 
and not the gradual development of symptoms years after injury has occurred.12   
Another highly discussed and debated repercussion of contact sports-related head 
trauma is Chronic Traumatic Encephalopathy (CTE), a pathologically diagnosed 
syndrome of neurological damage related to extensive history of RHI exposure.12  This 
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accumulation of impacts not only include the concussive events that athlete’s experience 
over the course of a career but also subconcussive impacts, which are defined as those 
with enough force to inflict neuronal damage without resulting in symptomatic 
concussion.32  CTE has been described to elicit several neurological impairments 
including behavioral, mood, and cognitive symptoms similar in many ways to that of 
pPCS.7  It is a progressive condition but in contrast to pPCS, is characterized by an 
insidious onset of clinical features following significant exposure to RHI.  In the majority 
of cases, these symptoms do not develop until several years after the maximal exposure 
period.7  
Though CTE and pPCS have a clear clinical distinction with regard to their 
expected timing of symptom onset, recognition of probable early-stage CTE can become 
difficult in cases where individuals who have been engaged in contact sports for many 
years suffer a concussive event leading to the acute onset and duration of symptoms 
consistent with pPCS.12  Though the clinical picture in this situation may lead to the 
presumed diagnosis of pPCS, it is possible that the symptoms related to concussion in 
these patients are bridging the latent period of what is developing CTE, or may even be 
masking what is a true manifestation of early stage CTE in the first place.  The question 
of how to distinguish pPCS from early stage CTE when clinical picture and history could 
make arguments for either has yet to be explored.12  
 3 
 
Statement of the Problem 
Following the deaths of several high profile athletes and the growing public health 
concerns regarding risks of participating in contact sports, the past decade has seen an 
extraordinary amount of attention and effort being allocated to the study of CTE with 
numerous institutions implementing research programs in attempt to characterize the 
disease from a clinical standpoint.  Likely the most challenging road block involved with 
attempting to define CTE is the fact that the disease can only be definitively diagnosed on 
post-mortem neuropathological examination.  As a result, the clinical features that have 
been described in CTE have been based primarily on retrospective interviews from 
family members of the deceased subjects who have been neuropathologically diagnosed.7  
In order to fully characterize CTE, its risk factors and epidemiology, and to perform 
clinical trials for prevention and treatment, the development of in vivo diagnosis for the 
disease is necessary.7   
 Current research is beginning to show promise in the development of sensitive 
and specific biomarkers for CTE which may eventually contribute to a support model for 
in vivo diagnosis.  Given the fact that many common neurodegenerative diseases and 
other conditions such as pPCS have clinical findings that mimic or overlap with CTE, it 
is important to distinguish these conditions from CTE in order to truly characterize the 
disease and place the correct candidates into studies for future biomarkers.  
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Hypothesis 
Patients with a history of sports-related RHI exposure and symptoms consistent with 
early stage CTE will have worse executive functioning compared to patients with non-
sports-related pPCS.  
 
Objectives and specific aims 
The purpose of this study will be to investigate a possible distinguishing variable between 
early stage CTE and pPCS that is measurable.  Evidence has shown that executive 
dysfunction is one of the earliest signs of cognitive decline associated with CTE.23  
Patients with pPCS have also been proven to exhibit impairments of executive function, 
however the progressive nature of cognitive decline in CTE opens the argument that 
these patients would eventually develop worsening executive function over time as 
compared to pPCS patients.  If it could be established that patients with probable early 
stage CTE had worse executive functioning than those with pPCS, it may be possible to 
use this measure as a distinguishing variable in clinical assessment.  Being able to 
distinguish or recognize probable early stage CTE versus pPCS could lead to a better 
understanding of the disease process of CTE and its relationship to acute concussive 
events and pPCS.  A better understanding of CTE will help guide future studies leading 
to improved diagnostic methods and ultimately possible management or treatment 
avenues.20 
1. Attempt to develop a measurable variable that may aid in distinguishing early 
stage CTE from pPCS.  
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2. Analyze the effects of football related RHI exposure and non-sports-related mTBI 
on executive function. 
3. Establish expected levels of executive function in patients with history of football 
exposure versus those with non-sports-related mTBI events, and develop a 
spectrum of clinical risk for probable early stage CTE versus pPCS. 
4. Analyze progression of executive dysfunction in pPCS patients and those at 
higher risk of having early stage CTE.  
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REVIEW OF THE LITERATURE 
Overview 
 
History of Head Trauma in Sports 
The link between neurological dysfunction and RHI in athletic competition was first 
identified in 1928 when Harrison S. Martland described a constellation of symptoms 
effecting professional boxers that he termed “punch drunk syndrome”.1  This condition 
involved mental confusion with an unsteady gait pattern in its earliest stages, with 
progression to parkinsonian-like symptoms and pronounced mental deterioration 
requiring commitment to asylums in its most severe cases.1  Martland concluded that 
since this condition was present in almost 50% of fighters and most often affected those 
who took considerable head punishment over their careers, there was strong evidence that 
some neurological disorder due to their occupation likely existed.1 
 In the years following Martland’s findings, the clinical impact of RHI continued 
to be investigated with various terms such as “traumatic encephalopathy of pugilists”, 
“dementia puglistica”, and finally “chronic traumatic encephalopathy” being introduced 
in 1949 to define the progressive condition.2-4  In 1973, the first description of pathologic 
characteristics of CTE were identified in deceased boxers by Corsellis, and throughout 
the remainder of the 20th century, the study of CTE focused primarily on boxers.5  In 
2005 however, the potentially serious public health implications of CTE were realized 
when Omalu and colleagues identified the first evidence in CTE in a professional football 
player.6  Following this finding, public interest and research in CTE escalated 
tremendously with evidence of CTE being found in former athletes of other contact 
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sports including ice hockey, soccer, rugby, and professional wrestling, as well as other 
individuals who had been subjected to repetitive brain trauma such as military veterans 
and victims of abuse.7   
In recent years, further research and knowledge of CTE has continued to amplify 
public health concerns and has even led to several changes in sports programs and 
leagues at all levels with regard to concussion protocol and exposure to head contact.  
Though awareness and understanding of sports-related head trauma and RHI have grown 
vastly since its origins in 1928, countless questions still remain and it may be many more 
years until researchers and clinicians are able to truly grasp this subject matter. 
 
Concussion 
As concern for the potential long term consequences of sport-related concussions 
continues to grow, the necessity to understand, recognize, and adequately treat/manage 
concussions has become a priority for many institutions.  Concussions are considered a 
subset of mild traumatic brain injury (mTBI) and consist of 75-95% of all TBIs.8  
Concussions are defined as any complex pathophysiological process onset by traumatic 
biomechanical forces which affect the brain.12  These traumatic forces can be caused by a 
direct collision with either the head, face, neck, or body with forces being transmitted to 
the head, and ultimately result in rapid onset of acute neurological impairments.  
Concussions are a clinical diagnosis which can be identified by assessment following 
head trauma.  The most common symptoms include headache and dizziness along with 
cognitive impairment such as confusion, and behavioral symptoms such as irritability.   
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Many other symptoms can manifest with concussion and are illustrated in Table 1.  Of 
note, loss consciousness only occurs in 10% of concussions and should not be considered 
necessary for diagnosis.13  
Table 1. Symptoms of Concussion. 
 
Physical Cognitive Emotional 
Headache Confusion Irritability 
Dizziness Disorientation Depression 
Nausea/Vomiting Memory deficits Anxiety 
Photophobia/Phonophobia Impaired concentration Mood swings 
Visual/Vestibular dysfunction Feeling mentally “foggy” Paranoia 
Numbness/tingling Loss of consciousness Apathy 
Fatigue Amnesia Sleep disturbance 
Impaired speech   
 
Epidemiology 
The Centers for Disease Control and Prevention (CDC) have estimated between 1.6 and 
3.8 million individuals in the United States sustain a sports-related concussion every year, 
and the probability of an athlete sustaining a concussion in a contact sport may be as high 
as 20%.9,10  Recent data has suggested that annual concussion rates have increased over 
the past decade, however it has been widely speculated that this increase is a result of 
improved concussion awareness and education leading to increased identification and 
reporting.13   Even still, the true incidence of sports related concussions is likely higher.  
It has been suggested that as many as 50% of athletes fail to recognize, report, or admit to 
symptoms, leading some to refer to concussions in sports as a “silent epidemic”.13   
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Pathophysiology 
The mechanism of injury involving concussions has evolved considerably over the past 
decades from merely being a “brain bruise” to a complex process involving brain and 
neuronal tissue, vasculature, and cellular metabolism.  The primary mechanism by which 
concussions occur is through rapid acceleration and deceleration of the brain, including 
both rotational and linear acceleration, and impact deceleration.12  The kinetic forces 
placed on the brain causes deformation of tissue triggering a cascade of neurochemical 
and metabolic events.  
First, the stretching of neural tissue that occurs during brain deformation causes 
axonal injury or shearing which releases ions across their membranes.  The disruption in 
axonal membrane potential causes a release of neurotransmitters, with glutamate in 
particular.  This excitatory neurotransmitter binds to N-methyl-d-aspartate receptors 
causing further membrane depolarization and calcium release.  The overload of calcium 
within tissue further disrupts axonal membrane potential, inhibiting proper function and 
communication between neurons.  In order to restore normal axonal membrane potential, 
the sodium-potassium pumps are required to work at extremely high levels, which in turn 
elicits the need for equally high levels of and oxygen and glucose for ATP production. 
However, decreased cerebral blood flow resulting from injury leads to a mismatch in 
supply and demand and inhibits the brain’s ability to properly restore normal cellular 
function.  This process of axonal injury and neuronal dysfunction, along with 
neuroinflammatory responses and production of free radicals are the basis of the many 
signs and symptoms brought on by concussions.14   
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Disease course and management 
In the 80-90% of sports-related concussion cases, symptoms usually resolve 
spontaneously within 7-10 days, though recent research has shown that this recovery 
period may be longer in the developing brains of children and adolescents.12,15  
Appropriate management of concussion can have a large influence on the length of 
recovery period for patients as well as the prospective implications of injury such as the 
development of PCS or second-impact syndrome, a potentially fatal condition.12  The first 
step in management consists of recognizing injury and immediately removing the player 
from competition.13  Following evaluation by a professional healthcare provider, it is 
recommended that patients undergo a period of physical and cognitive rest in order to 
reduce the metabolic needs of the brain and allow for healing of injured tissue.16  Once an 
athlete is asymptomatic from initial symptoms of concussion and does not develop 
further complications, a gradual return to competition should be overseen.  Athletes 
should only return to full activity until they are asymptomatic at rest and on exertion.12  
 
Post-concussion syndrome 
Though most athletes who suffer symptomatic concussions are able to make a full 
recovery to baseline within the average 7-10 day window, some are subject to symptoms 
that continue over a period of months or even years beyond their injury in a condition 
referred to as post-concussion syndrome (PCS).  There are two standardized definitions 
of PCS.  The Diagnostic and Statistics Manual, fourth edition (DSM-IV) defines PCS as 
cognitive deficits with attention or memory and a minimum of three or more of the 
following symptoms: headache, dizziness, fatigue, irritability, apathy, personality change, 
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or sleep or affective disturbance.15  To meet the DSM criteria for PCS, symptoms must be 
present for three months or greater.15  In comparison, the World Health Organization’s 
(WHO) International Classification of Diseases, tenth edition (ICD-10) characterizes PCS 
as the presence of three or more of the following symptoms that must be present within 
the first month post-injury including: insomnia, irritability, dizziness, headache, fatigue, 
and difficulty with concentration or memory.15  There is little agreement between these 
definitions in clinical practice and as a result, determining the epidemiology and public 
health implications of this condition have proven to be challenging.  
 
Epidemiology and risk factors 
The percentage of adult athletes that continue to experience concussion symptoms 
beyond the 7-10 day time frame is reportedly in the range of 10-30%.15  Many of the 
symptoms that manifest acutely with concussions can endure in PCS with the most 
common reported symptom being headache, which in most cases is described as more 
frequent and longer-lasting than prior to injury.17   About half of PCS patients report 
dizziness, irritability, depression, and anxiety.17  With regard to cognition, short term 
memory loss appears to be the most common symptom.  In a recent study, 25% of people 
diagnosed with PCS continued to report memory problems more than one year following 
injury.18  Overall however, most experienced clinicians tend to agree that cognitive 
symptoms of PCS resolve within 6 months to a year following injury in the vast majority 
of individuals.17  
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Several clinical variables have been thought to be associated with prolonged 
recovery from concussion and may predict the development of PCS.  Some of these risk 
factors include younger age, female sex, unconsciousness or amnesia at time of injury, 
history of previous concussion, pre-existing ADHD or mood disorders, headache or 
dizziness at time of injury, delayed symptom onset, and initial symptom burden.15  A 
recent study by Tator et. al. however reported considerable heterogeneity in the clinical 
demographics of 221 PCS patients who were studied.19  Notably, 23.1% of patients had 
been diagnosed with PCS following only 1 concussion which seemed to dispel the 
common theory that multiple concussions increase the likelihood of developing PCS.  
Given these findings, further investigation into the predictors, risk factors, and process of 
PCS will be necessary to shape our understanding of this condition. 
 
Persistent post-concussion syndrome 
Persistent post-concussion syndrome (pPCS) is a clinical phenomenon in which patients 
experience neurologic and behavioral symptoms following a concussion that do not seem 
to resolve.  The exact frequency of pPCS is unknown but reports have shown that 10-
15% of concussion patients continue to be symptomatic 1 year post-injury.12  Symptoms 
of pPCS are again similar to those in acute concussion and PCS, however emotional 
symptoms in pPCS seem particularly prominent and in some cases progressive.12  The 
etiology of pPCS and reasons for why post-concussive symptoms may not resolve in 
certain patients is debated.  Prolonged symptoms have been theorized to be related the 
mechanism of injury, the regions of the brain effected, or some other unknown 
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pathological substrate yet to be explored.28  However, it has also been theorized that some 
cases of pPCS may be a consequence of  maladjustment, depression, or unmet 
expectations in relation to recovery from concussion.28  A study by Lange et.al. noted that 
patients who experience a concussion and have a recovery period complicated by major 
depression report more post-concussion symptoms and more severe symptoms than 
outpatients with depression, and patients with concussions who do not report significant 
depression.29  This finding would suggest that depression may have a role in the 
prolonging of symptoms in pPCS and given the lack of an objective marker for this 
condition, the ability to draw a truly direct correlation between prolonged symptoms and 
a single concussion may be difficult.  
 
Chronic traumatic encephalopathy 
In recent years, the untimely and tragic deaths of several high profile athletes revealed to 
have evidence of CTE on post-mortem histopathological examination has led to an 
extraordinary surge in public interest and media attention regarding the disease. 
Considering the amount of athletes of all ages who participate in contact sports every 
year, CTE has become a significant public health concern, and many institutions are 
implementing great efforts to characterize this disease that is still not fully understood.  
As it currently agreed upon, CTE is defined as a progressive, neurodegenerative 
condition that develops in association with repetitive mTBI.7  This repetitive trauma is 
not simply limited symptomatic concussions, but also subconcussive blows to the head 
which can be quite numerous in certain contact sports, most notably football.  Over one 
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million high school athletes participate in football each year and with the size and speed 
of these athletes increasing according to recent studies, the public health implications of 
CTE could become rather significant in the years to come.7, 24 
 
Epidemiology 
The incidence and prevalence of CTE is largely unknown as cross-sectional and 
prospective studies are inhibited by the inability to definitively diagnose this disease in 
living patients.25,30  As a result, most epidemiological data regarding CTE has been 
derived retrospectively through pathological analysis of donated brains from athletes 
post-mortem.30  To date, neuropathologically confirmed cases of CTE have been 
discovered in subjects as young as 14 and as old as 98, and in former athletes who did not 
continue contact sports beyond the high school or collegiate level.10, 21   Cases have also 
been reported in non-athletes who have been exposed to other forms of RHI, including 
military personnel with blast exposure, epileptic and mentally disabled patients who 
frequently head-bang, physical abuse victims, and even a circus clown who was 
recurrently shot out of a cannon.10  The majority of cases however, have been noted in 
athletes of high impact sports such as football, ice hockey, wrestling, soccer, boxing, and 
rugby.10  
Retrospective studies and neuropathological examination have revealed some 
concerning statistics with one study finding evidence of CTE in 80% of athlete brains 
reviewed.21  However, estimates of prevalence from such subject groups are likely 
inflated by referral bias and may not represent the general athlete population.30  The 
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limitation to being able to report accurate incidence and prevalence rates for CTE once 
again highlights the need for in vivo diagnostic criteria for this disease. 
 
Subconcussive impacts 
An important development in the characterization of CTE with regard to etiology has 
been the role of subconcussive impacts.  Subconcussive injuries are defined as head 
impacts that involve enough force to disrupt axonal integrity but do not result in 
recognizable, symptomatic concussions.  The intensity of impact required to cause 
neuronal damage is unknown, and whether there are impact levels that do not disrupt 
neuronal function is yet to be determined.32  These events have become notable however, 
due to the fact that 16% of previous CTE cases have no reported concussion history 
leading to the suggestion that subconcussive impacts are sufficient to initiate the disease 
process of CTE.11   
In certain contact sports, especially football, the amount of subconcussive injuries 
that may accumulate over the course of a career can be quite numerous.  A study by 
Broglio et al. suggested that high school football players sustain an average of 24 head 
impacts per game exceeding 14 g-force.30   Another study determined that offensive 
lineman experience over 1000 subconcussive impacts exceeding 10 g-force over a single 
college football season.11  Similar results have been shown in male collegiate hockey 
players, indicating that a variety of athletes may endure a significant amount of head 
impacts every season.30 
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Though it is unknown whether a specific threshold of head impacts is necessary to 
cause the development of CTE, there appears to be a correlation between the amount of 
exposure to contact sports and severity of disease.  Samples reviewed by McKee and 
colleagues have shown that pathologic staging of CTE correlates significantly with the 
amount of years spent playing football.21  Position played also seems to have bearing on 
risk as studies of collegiate players suggest that offensive linemen develop more post-
impact symptoms and experience more subconcussive injury compared to other 
positions.11   Recent advances in protective equipment act to mitigate the effects of high-
impact forces, however they do not alleviate the effects of rotational forces experienced 
with head contact.  In addition, an athlete’s perceived lower level of risk with helmet use 
may spur more risky behavior during games, leading to more severe impacts.30 
 
Pathophysiology 
CTE is categorized a tauopathy which is pathologically distinct from that of Alzheimer’s 
disease (AD) and frontotemporal lobar degeneration (FTLD).  The neurodegeneration of 
CTE is associated with accumulation and widespread deposition of hyperphosphorylated 
tau protein (p-tau) as neurofibrillary and astrocytic tangles.11  CTE has been noted for its 
unique pattern of distribution found to preferentially involve the sulcal depths and 
perivascular regions of the brain.11  In addition, there is significant periventricular and 
subpial distribution with prominent accumulation of tau-immunoreactive astrocytes.11   It 
has been theorized that the specific distribution of p-tau in CTE is likely due to 
accumulation in vulnerable areas of brain tissue that are most susceptible to injury as a 
 17 
result of mTBI.11  The superficial layers of the frontal and temporal cortices tend to be 
the first areas of the brain affected by CTE.11  As the disease course progresses, p-tau 
deposition spreads to involve the adjacent cortices, diencephalon, and brainstem.11  Beta 
amyloid deposition as diffuse plaques has been seen in less than fifty percent of cases 
which seems to distinguish CTE specifically from AD.11   
 
Pathology 
As CTE is presently only diagnosed through post-mortem histopathological analysis, it is 
important to understand the common pathological findings and classification of this 
disease.  From a gross anatomical perspective, CTE is characterized by atrophy of the 
cerebral hemispheres, thalamus, mammillary bodies, and brainstem, with ventricular 
enlargement and a fenestrated cavum septum pellucidum.10  Microscopically, there are 
extensive tau-immunoreactive neurofibrillary and astrocytic tangles, and spindle-shaped 
and threadlike neurites throughout the brain.10   Being a progressive disease, it is helpful 
to define CTE in terms of stages.  McKee and colleagues have developed a commonly 
used outline which classifies CTE into 4 stages.12  The pathological findings of these 
stages are described further in Table 3 along with their clinical associations.  Progression 
between each stage of CTE has been estimated to be 11 to 14 years.21 
 
Clinical Features 
Since Martland’s initial studies in the early 20th century, a plethora of different clinical 
signs and symptoms have been used to describe CTE.  However, overall consensus seems 
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to agree on a core characterization of progressive deficits in behavior, mood, cognition, 
and motor function which seem to correlate with the anatomic distribution on 
neuropathology as a result of disease.25  Another challenge of defining the true clinical 
features of CTE is the fact that most symptoms have been described retrospectively by 
family members of brain donors.  Recently however, Montenigro et al. reviewed 
literature of the clinical presentations of CTE from 202 published cases and categorized 
the most common descriptions as summarized in Table 2.7  
Table 2. Summary of clinical features for previous CTE cases. 
 
Behavioral Mood Cognitive Motor 
Aggression Depression Memory impairment Ataxia 
Explosivity Anxiety Loss of concentration Dysarthria 
Impulsivity Apathy Executive dysfunction Parkinsonism 
Paranoia Suicidality Dementia Tremor 
Physically/verbally 
violent 
Mood swings Language difficulties Gait disturbance 
 
The review also identified two relatively distinct clinical manifestations of CTE with one 
group exhibiting initial features in behavior and/or mood while the other seemed to have 
initial features involving cognitive dysfunction.  It was also noted that symptom onset for 
the ‘behavior/mood’ group occurred at a significantly younger age compared to the 
‘cognition group’, and that most subjects in the behavior/mood group eventually 
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developed cognitive symptoms.7  Less than a third of the cases reviewed had reported 
motor features such as Parkinsonism.    
In the majority of CTE cases, symptoms develop insidiously and generally begin 
8-10 years after experiencing RHI exposure, though evidence of CTE has been found in 
subjects who were actively participating in contact sports at time of death.10  With regard 
to symptom progression, McKee et al. recently characterized the four main pathological 
stages of CTE with symptoms that progressively worsen with extent of pathological 
changes.21  The pathology and symptoms described in Table 3 are noted to be cumulative 
through disease progression.  
Table 3. Neuropathology and clinical symptoms based on CTE stage. 
 
Stage Pathology Symptoms 
Stage I Gross: None 
p-tau: Sulcal depths of frontal cortex  
-Headache 
-Loss of concentration 
-Reduced attention span 
Stage II Gross: Mild ventricular enlargement, 
cavum septum pellucidum, pallor of 
locus coeruleus and substantia nigra 
p-tau: Subcortical white mater, medial 
temporal lobe, brainstem 
-Pronounced behavioral/ 
personality changes (depression, 
impulsive behavior) 
-Short term memory loss 
-Executive dysfunction 
Stage III Gross: Reduced brain weight, mild 
frontal/temporal atrophy 
p-tau: Diffuse in frontal, temporal, and 
parietal cortices, concentrated around 
small vessels and sulcal depths 
-Further cognitive impairment 
-Aggression 
-Mood disorders 
Stage IV Gross: Pronounced atrophy and 
reduction in brain weight. Septal 
abnormalities 
p-tau: Severe deposition, inclusion of 
cerebellum and medulla 
-Severe mood disorders 
-Language difficulties 
-Visuospatial difficulties 
-Gait/motor control impairments 
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As with the findings described by Montenigro et al., behavioral/mood symptoms 
appear to be the earliest manifestation in the majority of CTE cases with cognitive 
symptoms becoming more pronounced in stages II-III and motor symptoms developing in 
late-stage disease.  Based on informant interview and previous neurological examination 
on patients prior to death, the earliest cognitive deficits of CTE tend to be in the areas of 
memory and executive function.25  
 
Executive function 
Executive function is defined as the mental capacities required for effective goal-directed 
activity and cognitive control of behavior.35  It is involved in complex mental processes 
such as problem solving, behavior modification in setting of new information, strategy 
generation, and sequencing complicated actions.35  These functions are dependent on the 
prefrontal brain areas and on links between dorsolateral frontal and parietal cortices 
which, as stated previously, are regions of the brain commonly affected in the early 
stages of CTE progression.  
 
Behavior rating inventory of executive function (BRIEF) 
The Behavior Rating Inventory of Executive Function (BRIEF) test was developed in 
2000 to assess executive function and behavior in children and adolescents with a variety 
of neurological conditions including autism, Tourette syndrome, TBI, and most 
commonly, Attention deficit/hyperactive disorder (ADHD).  The BRIEF-Adult version 
(BRIEF-A) was developed 2005 as an extension of the original test and has been proven 
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to be useful in assessing older patients with neurological/psychiatric disorders, dementia, 
and TBI as well.  The BRIEF-A consists of a 75-item questionnaire that can be completed 
either by the patient or an informant involved with care.  Participants indicate how 
problematic certain behaviors have been over the previous 30 days on a 3-point scale: 
never (1 point); sometimes (2 points); or often (3 points).32  The overall score called the 
Global Executive Composite (GEC) is broken down into two indices: Behavior 
Regulation Index (BRI) and Metacognition Index (MI).  The BRI measures ability to 
control behavior and emotional responses, while the MI measures ability to solve 
problems, plan, organize, and sustain a working memory.  These indices are calculated 
from a total of nine clinical scales which are described in Table 4.  Scores are compared 
to normalized data previously obtained from 1050 participants selected to proportionally 
represent the United States population with regard to sex, race/ethnicity, education, and 
geographic region.27  Higher scores relative to normative data indicate more executive 
dysfunction, with scores 1.5 standard deviations above the mean being considered 
clinically significant.   
Table 4. BRIEF-A Clinical scales. 
 
Behavior Regulation Index (BRI) Metacognition Index (MI) 
Inhibit Ability to control impulses 
and to stop engaging in a 
behavior. 
Initiate Ability to begin an 
activity and to 
independently generate 
ideas or problem-solving 
strategies. 
Shift Ability to move freely from 
one activity or situation to 
another; to tolerate change; 
Working 
Memory 
Ability to hold 
information when 
completing a task, when 
encoding information, or 
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to switch or alternate 
attention. 
when generating goals/ 
plans in a sequential 
manner. 
Emotional 
Control 
Ability to regulate emotional 
responses appropriately. 
Plan/Organize Ability to anticipate 
future events; to set goals; 
to develop steps; to grasp 
main ideas; to organize 
and understand the main 
points in written or verbal 
communication. 
Self-
Monitor 
Ability to keep track of the 
effect of one's own behavior 
on other people. 
Task-Monitor Ability to assess one's 
own performance in 
problem solving tasks. 
Organization 
of Materials 
Ability to put order in 
work, living, and storage 
spaces  
 
Existing research 
In concordance with the growing concerns on the issue of sports-related head trauma and 
repetitive impacts, a great deal of research and new information has been published on 
this subject.  Several of these studies have also concentrated particularly on the effects of 
head trauma on executive functioning and other related aspects of neuropsychological 
health.  The results of many of these studies have shown troubling statistics with regard 
to neurological deficiencies in current and former contact sport athletes, and the 
conclusions they have drawn continue to emphasize the necessity for further research.      
 In attempt to illustrate the acute and residual neuropsychological effects of sport-
related mTBI, Killiam et al. studied a cohort of collegiate contact sport athletes.  
Participants in this study were assigned to one of four groups: non-concussed, non-recent 
concussed (>2 years), recently concussed (<2 years), or a control group of non-
concussed/non-athletes.  Subjects were assessed on executive functioning using 
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neuropsychological (NP) tests focused on working memory, visuospatial construction, 
language, and attention.  Results of testing showed no difference in visuospatial 
construction, language, and attention among the four groups but significant deficits in 
working memory were identified for the concussed athletes (both recent and non-recent) 
relative to the control group.33  This finding would suggest that there some degree of 
executive impairment in the acute and chronic periods for previously concussed athletes, 
however data also revealed a significant difference in this area for recently concussed 
relative to non-recent, suggesting a level of improvement to function over time.  Of note, 
overall results of NP testing showed significantly lower scores for not only concussed 
athletes relative to non-athletes, but non-concussed athletes as well.  This finding 
highlights the potentially large role that subconcussive impacts play in executive function 
impairment, especially given that no statistical differences were found between the 
concussed and non-concussed athletes.33   
Though these may be crucial findings, this study was limited by a small sample 
size and the fact that students were all selected from the same college, making data less 
generalizable.  Participants were also asked to only list concussions that were diagnosed 
by a physician on screening questionnaires.  This differs from protocol of more recent 
studies in which subjects self-report concussion history based on a modernized definition, 
and not just from clinical diagnoses.  In this regard, it is possible that athletes in the non-
concussed group may have had previous concussion as considered by current standards.  
 Another deficiency in the Killiam et al. study is that it did not designate a group 
specifically for post-concussion subjects who remained symptomatic.  A more recent 
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study by Dale et al. however, takes this variable into account by comparing post-mTBI 
patients with pPCS to those without, as well as control groups that included non-mTBI 
patients who were experiencing symptoms consistent with PCS according to DSM-IV 
criteria.34  The groups were designated as mTBI + PCS, mTBI – PCS, Control + PCS, 
and Control – PCS with the mTBI groups being ≥1 year post injury and the control 
groups having no prior history of head injury.  Participants all underwent various 
behavioral and neurocognitive tasks to assess executive functioning.   
Results revealed that the mTBI + PCS group had significantly greater error rates 
in cognitive tasks than all other groups, including mTBI – PCS.  Comparison of all other 
groups were not statistically significant.  With regard to executive function, the mTBI + 
PCS group demonstrated significant impairment in working memory and information 
processing speed compared to all other groups.   
It could be argued that the deficiencies seen on testing for the mTBI + PCS group 
relative to the mTBI – PCS group may be secondary to effects of symptoms.  In attempt 
to control for this variable, the study utilized the Control + PCS group and compared the 
symptoms reported in each group.  While depression/anxiety symptoms did not vary 
between the +PCS groups, the mTBI + PCS group did have increased symptom report in 
sleep quality and PTSD.  It was also found that symptom report (i.e. amount of sleep 
deprivation) correlated with decreased test results.  Given this outcome, Dale et al. 
ultimately concluded that the executive function impairment seen in the mTBI + PCS 
group was most likely due a combination of symptom effect and that of the initial injury.  
Ultimately, further investigation on effects of sleep quality and PTSD in pPCS patients 
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along with longitudinal studies would prove more useful in characterizing executive 
dysfunction for pPCS.         
 Though there is limited data with respect to the longitudinal neuropsychological 
and cognitive outcomes of patients with history of RHI, researchers are working towards 
developing methods to help answer the many questions surrounding the long-term 
consequences of participating in contact sports.  The Longitudinal Examination to Gather 
Evidence of Neurodegenerative Disease (LEGEND) study at Boston University’s 
Alzheimer's Disease and CTE Center is one such study.  LEGEND is designed to assess 
the potential risk factors involved with the short and long-term implications of mTBI and 
RHI exposure.  Participants in this study undergo annual cognitive assessments, and 
internet-based measures of mood, behavior, and cognition.  Participation in LEGEND is 
open to adults over the age of 18 who are either active or former athletes involved with 
any sport and level of competition.  There are currently about 800 current/former athletes 
participating in this study.32  
 As a segment of the ongoing LEGEND study, Montenigro et al. recently looked 
to quantify the impact of sports-related RHI on long-term neurological function.  The 
study made use of a metric called the “cumulative head impact index” (CHII) which was 
generated from a combination of self-reported athletic history (amount of seasons, 
positions, and levels played) and impact frequencies based of previous helmet 
accelerometer studies which quantified frequency of head impacts per season by position 
and level of play.32  The study sample included 93 former high school and collegiate 
football players enrolled with LEGEND.  
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Participants completed questionnaires to assess past medical history and 
concussion history along with athletic history.32  They then completed several self-
assessment surveys which measured levels of depression, mood, cognitive function, and 
executive function.  The CHII calculated from athletic history served as an estimate of 
the total exposure to RHI participants had experienced over a lifetime of playing football.  
This estimate was used as a predictor metric and was modeled with each outcome of the 
self-assessments.32  With statistical analysis, researchers were able to identify CHII 
threshold points for which the risk of neurological impairment begins to increase above 
that of the normal population.  As data also showed a correlation between increasing 
CHII and risk of impairment, these thresholds essentially represented change points in 
which a dose-response is initiated.32  These change points are listed in Table 5.  
Table 5. Change Point threshold from baseline risk to Dose-Response Relation for 
CHII and Impairment Risk. 
 
Clinical Domain Threshold-mean CHII 
for dose-response 
95% Confidence Interval 
Executive Function 1850 1523-2011 
Depression 1801 1514-2010 
Apathy 2160 1536-5754 
Cognition 7251 1754-9788 
 
According to this data, the amount of head impacts estimated to initiate an 
increased risk of executive dysfunction above the normal average is 1,850.32  This 
impairment threshold is only achieved earlier by depression, and for a high school 
athlete, this level of CHII could be achieved in about 3 seasons of play.32  This risk 
increases with a higher CHII as illustrated in Figure 1 and with a mean CHII of 5,806 for 
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this study sample, the average risk of executive dysfunction was increased almost 5 fold 
for these athletes.  
 
 
 
Figure 1: Dose-Response Relationship for CHII-Executive Dysfunction Risk.  
 
The results from this study also proved CHII to be a better predictor of 
impairment than self-reported concussions.32  This may imply that total RHI has a greater 
effect on executive dysfunction than do isolated concussions, but it may also demonstrate 
the inaccuracy of self-reporting concussions in studies in the first place.  Regarding the 
validity of CHII, a notable weakness is its assumption that players are active for all 
games and practices throughout the season.32  Regardless, the results of the study 
highlight the importance of subconcussive impacts in the development of neurological 
impairment as a correlate with duration of contact sport exposure. 
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 Another segment of the LEGEND study by Seichepine et al. seems to illustrate 
the progressive nature of executive function decline in individuals with RHI exposure 
who are likely to be at high risk of either having or developing CTE.  The study looked at 
executive function in college and professional football players through self-assessment 
using the BRIEF-A.  The use of this particular measurement allowed researchers to 
compare results of these athletes with the normative scores for healthy adults, as well as 
compare the results of athletes themselves by age.  The BRIEF-A test was also 
considered advantageous as previous research has shown it to be more sensitive in 
detecting early executive deficits compared to other objective measures of cognitive 
function.27  
Participants in this study included 64 current and retired football players, of which 
were all males ranging from 25 to 81 years of age (mean age of 47.0 and standard 
deviation of 13.6).  Subjects were grouped by level achieved in football (college and 
professional) and by age (less than 40 and greater than or equal to 40).  This age grouping 
was chosen based on evidence that cognitive decline and other profound CTE symptoms 
appear to develop in the fourth or fifth decades of life.27  Once BRIEF-A scores were 
obtained, they were converted to age-appropriate t-scores based on normative data.  
In comparing BRIEF-A results of football players and normative data for healthy 
adults (t=50), football players indicated greater decline in executive function with 
significant elevations on the GEC (t(63)=5.4; p<0.05), MI (t(63)=5.3; p<0.05), and BRI 
(t(63)=5.2; p<0.05) indicies.27  Analysis of the individual clinical scales also showed 
significant deficiencies for football players on seven of the nine scales: inhibit, shift, 
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emotional control, initiate, working memory, plan/organize, and task-monitor.27  Across 
all scales, football players indicated worse functioning and had higher rates of clinically 
elevated scores (t-score ≥65) than the normative sample.27    When comparing football 
players by age group, the ≥40 group showed significant differences in executive function 
compared to younger players with the three overall indices of GEC (t(62)=2.7; p<0.05), 
on the BRI (t(56.0)=3.3; p=0.05); and on the MI indices (t(62)=2.1; p<0.05) elevated as 
well.27  These findings would suggest that executive dysfunction in football players is 
either a progressive component that is set in motion from onset of RHI or that it becomes 
significantly worsened after 40 years of age.  Ultimately, longitudinal studies are 
necessary to better understand this data. 
Though the BRIEF-A does provide several advantages in this study, a notable 
weakness in its use is the fact that a population of elite athletes may not be generalizable 
against the normative data.  There are likely many differences in these groups including 
physical stature (height and weight), education (many players in this study attended 
college), overall health (heart disease, arthritis, chronic pain, orthopedic issues, use of 
medications), and health-related behaviors (alcohol, smoking, and illicit drugs).27  
Comparison of this data to non-contact athletes would strengthen the argument that 
executive dysfunction is a direct result of cumulative RHI.   
Another weakness to consider for this study its self-referral recruitment which 
may have included mostly players who were symptomatic and more concerned about 
their cognitive function than those who were not experiencing symptoms.  If this were a 
major bias however, there likely would have been few scores within the normal range for 
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football players.  In contrast, 31.3% of the players had overall scores at or below the 
expected value for their age.27 
Neuropsychological function has also been studied in individuals who have 
sustained multiple concussions but not in the setting of repetitive subconcussion 
exposure.  Vynorius et al. recently assessed the effects of multiple mTBIs on self-
reported cognitive difficulties, executive functioning, and mood in individuals who were 
not athletes.  The study sample consisted of 58 young adults (mean age of 22.84 and 
standard deviation of 4.88) of which 29 denied history of mTBI, and 29 reporting 2 or 
more mTBIs in their lifetime (range 2–7).31  Participants in this study were also assessed 
on executive function using the BRIEF-A, along with two other self-report tools to assess 
overall cognition over the previous five years and depression in the previous two weeks.   
Results of the three self-assessments showed that subjects with a history of 
multiple mTBIs reported a greater amount of depression symptoms, more change in 
cognitive function, and more problems with executive function in the previous 30 days 
compared to those without history of mTBI.31  Further analysis of the BRIEF-A results 
showed a significant elevation in the MI index but not in the BRI (p=0.066).31  
Additionally, it was found that an increased number of mTBIs reported by individuals 
correlated with an increased reporting of symptoms across all measurements.31  These 
findings would indicate that individuals with history of mTBIs but without history of 
contact-sports related RHI also experience a level of cognitive decline and executive 
dysfunction which worsens with subsequent injuries.   
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As with the Killiam et al. study, these results were limited by a relatively small 
sample size and having participants as college students from a single institution.  
Variables such as socioeconomic status, average amount of sleep, and learning 
disabilities were also not addressed in the study, and these variables may have 
contributed to the results of the three self-assessments.31  Nonetheless, the findings of this 
study are consistent with the growing evidence that any history of head trauma, whether 
it be isolated mTBI events or years of RHI exposure, seem to be associated with some 
degree of executive dysfunction and long-term, progressive decline.  How this decline 
differs between non-athletes with pPCS and contact sport athletes who may be 
experiencing early symptoms of CTE requires further investigation.   
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METHODS 
Study design 
The proposed study will be a cross-sectional analysis of executive function in non-
athletes and football players using two control groups and two study groups.  The first 
control group will consist of non-pPCS subjects without history of mTBI or contact 
sports exposure (Non-Football – pPCS).  The second control group will involve subjects 
with football exposure who are without symptoms of PCS (Football – pPCS).  The first 
study group will include pPCS patients with a non-athletic related mTBI history and no 
previous exposure to contact sports (Non-Football + pPCS).  The final group will be 
comprised of pPCS patients with football related mTBI and a significant history of RHI 
exposure that could raise suspicion of what may ultimately be a manifestation of early 
stage CTE (Football + pPCS).  Subjects will undergo self-assessments of executive 
function using the BRIEF-A assessment.  Results will be compared to determine if 
significant differences in executive function exist between the groups.  This study will 
work in parallel with the ongoing LEGEND study at Boston University.     
  
Study population and sampling 
The study population for the Non-Football groups will be selected from family medicine 
and neuropsychology practices across the New England region. Those that qualify under 
the specified inclusion/exclusion criteria as detailed in Table 6 will be selected to 
proportionally represent a variety of races, socioeconomic statuses, and educational 
backgrounds consistent with the United States population. 
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Table 6. Inclusion and Exclusion Criteria. 
 
Non-Football – pPCS Non-Football + pPCS 
Inclusion Exclusion Inclusion Exclusion 
Male, age 18-40 History of 
neurological 
disorder or learning 
disability  
Male, age 18-40 History of 
neurological 
disorder or learning 
disability  
 Any exposure to 
contact-sports, 
military experience, 
or other history of 
RHI  
Symptoms ≥1 year 
under DSM IV 
criteria for PCS 
Any exposure to 
contact-sports, 
military experience, 
or other history of 
RHI  
 History of 
substance and/or 
alcohol abuse 
History of single or 
multiple non-
sports-related mTBI 
History of 
substance and/or 
alcohol abuse 
 Any history of TBI  Any TBI sustained 
w/in year of study 
 
Football – pPCS Football + pPCS 
Inclusion Exclusion Inclusion Exclusion 
Male, age 18-40 History of 
neurological 
disorder or learning 
disability  
Male, age 18-40 History of 
neurological 
disorder or learning 
disability 
Exposure to 
football at high 
school level or 
higher 
Exposure to other 
contact-sports, 
military experience, 
or other history of 
RHI  
Symptoms ≥1 year 
under DSM IV 
criteria for PCS 
Exposure to other 
contact-sports, 
military experience, 
or other history of 
RHI 
CHII ≥4500 History of 
substance and/or 
alcohol abuse 
Exposure to 
football at high 
school level or 
higher 
History of 
substance and/or 
alcohol abuse 
 Any TBI sustained 
w/in year of study 
CHII ≥4500 Any TBI sustained 
w/in year of study 
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The study population for the Football groups will be selected from the current 
pool of LEGEND study participants.  Demographic characteristics, athletic experience, 
concussion history, and psychiatric history have already been obtained for these 
individuals, and those who meet group criteria as specified in Table 6 will also be 
selected to represent a variety of demographics and backgrounds consistent with the 
current population.  
Participants of the study will be between the ages of 18-40.  This parameter is 
necessary given the proclivity for younger CTE subjects to develop the behavior/mood 
symptoms that tend to mirror pPCS.7  It will also exclude the age groups in which 
cognitive symptoms of CTE are known to begin strongly manifesting based on previous 
evidence.7  Cognitive impairment may already be prominent in these individuals, which 
could lead to the possibility of skewed data.  
 Subjects for the + pPCS groups will be selected based on diagnostic criteria of the 
DSM-IV definition of PCS which requires changes in attention or memory and a 
minimum of three or more symptoms including; headache, dizziness, fatigue, irritability, 
apathy, personality change, or sleep or affective disturbance.15  Patients who are 
symptomatic for at least 1 year will be included in the study.  The Non-Football group 
will consist of subjects with pPCS following a non-sports-related concussion (e.g. car 
accident).  Subjects in this group may have a history of multiple concussions prior to 
development of pPCS, but will have no previous exposure to repetitive subconcussive 
impacts such as that experienced in contact-sports or military service.    
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 Given the historically limited participation of females in football, subjects in the 
study will be exclusively male.  The study will make use of the CHII estimate for football 
related RHI developed by Montenigro et al.32  Using this measurement rather than “years 
of contact sport exposure” would exclude participants who had played other contact 
sports, however its use will also control for several variables and provide a realistic 
estimate of RHI for participants.  The minimum CHII will be 4,500 for inclusion in the 
Football groups.  This number would equate to roughly 4 years of high school and 2 
years of college football.   
The sample size for this study will be based on outcome variable of BRIEF-A 
scores.  Previous studies using the BRIEF-A have been able to use smaller sample sizes 
as data was compared against the test’s normative data.  In comparing average scores 
between four independent groups however, larger sample sizes will be required.  While 
an increase in BRIEF-A scores of 15% above the normative average are considered 
clinically significant, this study will consider a difference of 10% between each of the 
four groups to be significant.  With an α-value of 0.05 and a power of 80%, the sample 
size required for each group will be 140.36  
 
Study variables and measures 
The primary variable of this study will be exposure to football-related subconcussion.  
Given that all previously studied cases of CTE have involved exposure to repetitive 
subconcussion, including 16% with no concomitant history of symptomatic concussion, 
this variable should prove to play an important role in discerning potential cases of early 
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stage CTE and true cases of pPCS within the Football + pPCS and Non-Football + pPCS 
groups respectively.22   
Cumulative RHI for the Football groups will be measured with the CHII 
calculated from athletic history and previous accelerometer data.  Participants in the 
study groups will undergo a one-time BRIEF-A assessment to measure level of executive 
functioning in the previous 30 days.  Results will be converted to age-appropriate t-scores 
based on published normative data.  These t-scores will then be compared to determine if 
a significant difference in executive function exists between the control and study groups 
as well as the study groups of Non-Football + pPCS and Football + pPCS themselves.  
Scores for the GEC, BRI, MI and the individual clinical cases described previously in 
Table 4 will all be calculated and compared.  A difference of 10% on all scores and 
clinical scales will be considered significant.   
 Multiple, symptomatic concussion history among the Football and Non-Football 
+ pPCS groups will be controlled as a variable by pairing scores for each group based on 
the amount of concussions sustained over a lifetime, e.g. football players with a history of 
3 symptomatic concussions will be compared with non-athletes with 3 concussions.  
Concussion history will be self-reported on screening questionnaires with a definition 
used in previous LEGEND studies and consistent with current guidelines from the 
American Academy of Neurology.  
 Age as a variable will be controlled through the age adjusted t-scores.  Other 
secondary variables to consider are past medical history, amount of symptoms reported, 
level of competition achieved in football, and severity of mTBIs. 
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Recruitment 
Subjects from the Football groups will have previously been recruited for the LEGEND 
study and will only require an additional email that would include a link to a screening 
questionnaire.  Subjects for the Non-Football groups will be recruited using flyers posted 
at family medicine and neuropsychology practices across New England.  These flyers 
would direct potential subjects to an online source where the screening questionnaire 
could be accessed and submitted to a database.  
 
Data collection 
The BRIEF-A is a self-assessment requiring only a pencil and 10-15 minutes to complete.  
This assessment is currently not available online, and will be mailed to participants.  For 
this study, one survey will be administered for each participant to assess executive 
function over the previous 30 days.  Raw scores will be computed with the BRIEF-A 
Software Portfolio (BRIEF-A SP) which requires 15-20 minutes.  This program will also 
convert raw scores into age-appropriate t-scores based on the published normative data as 
previously collected by the developers of BRIEF-A.   
 
Data analysis 
The t-scores for all four groups will first be compared against the normative data to 
identify any levels of dysfunction against the average population.  Mean t-scores for the 
Non-Football, and Football groups will then be calculated, and each group will be 
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compared with a two-sample t-test in order to identify any significant differences.  The t-
scores can also be adjusted to compare level of executive dysfunction by increasing age, 
lifetime concussions, and total CHII within each group.  These comparisons may provide 
evidence on how executive function declines with age, increased concussion history, and 
increased exposure to football.  
 
Timeline and resources 
Fall 2017 -Apply for IRB expedited review  
-Obtain approval to recruit in New 
England family medicine practices 
Winter-Spring 2018 -Recruit participants  
Spring 2018 -Obtain materials for the BRIEF-A 
assessment  
-Mail assessments to subjects who qualify 
and agree to study 
Summer-Fall 2018 -Data collection 
Fall 2018 -Study completion 
-Prepare and submit manuscript for peer 
review 
 
Resources needed for this study mainly include the materials for the BRIEF-A test 
administration and scoring.  As far as recruitment, the Football groups will already have 
been made available through the LEGEND study.  Recruiting for the and Non-Football 
groups will require several co-investigators in order to solicit the use of recruitment flyers 
in physician’s offices.  Undergraduate and graduate student volunteers interested in this 
area of research could be utilized to support the LEGEND personnel with mailing and 
receiving BRIEF-A tests, as well as administering phone calls to encourage participants 
to complete assessments in a timely manner. 
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Institutional Review Board 
As LEGEND has received prior IRB approval, this proposed branch of study will be 
submitted for expedited review as it involves a survey to proposed additional participants 
of a low risk, non-vulnerable population.  
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CONCLUSION 
Discussion 
The ultimate goal of the proposed study will be to identify evidence of a possible 
measurable variable between early stage CTE and pPCS, as well as further define each 
condition as separate disease processes.  It should be emphasized that this study does not 
specifically compare early stage CTE with pPCS however, as the lack of an in vivo 
diagnosis for CTE predicates this as a study limitation.  The rationale behind the design 
of this proposal is based on the fact that all previously studied cases of CTE have 
involved a significant degree of exposure to subconcussion.22  Therefore, this design is 
based on the assumption that a symptomatic Football + pPCS group will likely contain 
more cases of early stage CTE than the Non-Football + pPCS group, which should be 
represented to a greater extent by true cases of pPCS.  This assumption may be a 
limitation in itself but based on evidence from previous studies, would give the 
proposal’s results some merit to clinical application and hopefully provide evidence that 
would direct future studies down the correct pathways.   
 Advantages of this proposal relative to similar previous studies would certainly 
include its sample size and generalizability.  The total sample will contain a pool of both 
athletes and non-athletes made up of a variety of demographics and socioeconomic 
backgrounds.  As with the Seichepine et al. study, this proposal will also be designed to 
investigate the nature of progression in executive dysfunction for these particular 
individuals.  In this case however, the focus will be on the <40 year old population and 
include symptomatic individuals in the study groups.  Results under these parameters 
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may provide further clues into the potential decline of executive function in pPCS 
patients versus those at greater risk of having early stage CTE.  Any significant 
difference or recognizable patterns in this data may prove to be very beneficial in future 
studies. 
 Beyond the limitation of assumptions as previously stated, the proposed study 
includes other weaknesses that should be noted.  First, it will not include female 
participants, and with studies showing higher prevalence of women reporting prolonged 
symptoms of concussion, this exclusion may prove to be a considerable limitation in data 
collection.19  The study will also only include athletes with exclusive exposure football 
which would prevent the generalizability of results with other contact sports.  Finally, 
though the BRIEF-A has proven to yield accurate measurements of executive functioning 
in previous studies, it is purely a subjective measurement.  The involvement of an 
objective assessment such as cognitive testing would likely strengthen the results of this 
proposed study.    
 
Summary 
With the body of evidence that has been revealed with respect to the acute and long-term 
effects of contact sports-related RHI, the risks of participating in these sports, especially 
football, can no longer be understated.  The evidence in literature and statistics from 
current research show that neuropsychological and cognitive health can all be markedly 
compromised even at a young age for these athletes, and even in those who have never 
sustained a symptomatic concussion.  The recent efforts to better diagnose, recognize, 
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and manage concussions and their related symptoms have supported the campaign 
against this “silent epidemic” but clearly the best clinical solution to prevent the 
detrimental, long-term consequences of RHI is to is to recommend against the 
participation in contact sports.  As this is not quite an acceptable answer from a cultural 
stand point at present, our next best option is to continue researching these athletes and 
work towards finding risk factors, genetic predispositions, and in vivo diagnostic models 
for conditions such as CTE and pPCS. 
Regarding the potential of distinguishing these two conditions in situations where 
clinical picture is questionable, it would seem that a patient’s risk of having early stage 
CTE over a diagnosis of pPCS would increase with amount of RHI exposure they had 
experienced.  Whether there is a threshold of ‘years playing contact sports’ or total RHI 
that predicts this risk remains unknown, but the proposed study may help guide future 
studies in revealing that answer.  As previous studies have shown that worsening CTE 
pathology and worsening executive functioning are both correlated with increased RHI 
exposure, the argument that potential early stage CTE patients with significant exposure 
to RHI would exhibit worse executive functioning than that of true pPCS patients 
certainly warrants further investigation.21, 32   
 
Clinical and/or public health significance 
If results of the proposed study prove the initial hypothesis to be true, then the BRIEF-A 
scores obtained from this study could be applied clinically to assess a patient with pPCS 
symptoms and a history of contact sports exposure as to whether or not there should be 
 43 
concern for early stage CTE based on level of executive functioning and scoring 
spectrum of the Football and Non-Football groups.  Even if the results of this study do 
not show any significant findings between the groups, the statistics generated from it will 
give researchers and clinicians a better understanding and measurable expectation of the 
effects of RHI on executive functioning in contact sport athletes. 
As has been the conclusion for many other studies on this subject, the findings of 
a longitudinal study will ultimately prove to be the most beneficial in characterizing CTE 
as a disease.  The efforts to see such research through are well within the abilities of the 
LEGEND team at Boston University, however it may still require several years, even 
decades, until research yields truly tangible results.  Smaller studies such as the one 
proposed will aid efforts of the LEGEND study and clue researchers into what level of 
RHI history would push the clinical picture of a symptomatic individual in the direction 
of probable early stage CTE rather than pPCS.    
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